Marechale Capital Plc - Half-year Report
("
Half-yearly Results
Chairman’s Statement
A difficult first half to the Company’s year has been a feature of recent years, with 2025 being no exception, particularly with the SME market being challenging. However, the market started to pick up in
During the six months ended
The Company’s balance sheet shows a net asset value of £3,063,198 (2024: £3,183,537), representing 2.56p (2024: 3.01p) of value per share in issue. The Board remains positive about the investments that it holds in its client companies, and in particular its core investment in
Whilst there have been delays in completing some advisory projects during the Period, on a positive note, Marechale has in the last few months completed both debt and equity growth round transactions for
Cash at bank as at
The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with various potential businesses and individuals.
This plan to continue to develop Marechale’s strategic partnerships in order to enhance shareholder value, and develop new funding partners alongside its traditional investor relationships, has culminated in the successful completion of a placing in Marechale shares in October (as previously announced); this brought in two new strategic investors as well, in addition to all the Company’s directors investing too.
Whilst the current economic climate is difficult,
Chairman
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
For further information please contact:
Marechale Capital
Tel: +44 (0)20 7628 5582
Mark Warde-Norbury / Patrick Booth-Clibborn Cairn Financial Advisers LLP
Tel: +44 (0)20 7213 0880
Jo Turner / Sandy Jamieson
Income Statement (unaudited)
6 months ended 31 October 2025 2024
£ £
Revenue 111,932 148,500
Cost of sales (56,622) (45,032)
Gross profit 55,310 103,468
Administrative expenses (232,376) (241,953)
Operating loss (177,066) (138,485)
Exceptional credit 600 10,316
Loss on disposal of investments - (49,837)
Interest paid (49) (255)
(Loss) before tax (176,515) (178,261)
Taxation - -
(Loss) after tax (176,515) (178,261)
(Loss) per share
(Pence) (Pence)
- Basic (0.17) (0.17)
- Diluted (0.17) (0.17)
Balance Sheet (unaudited)
As at 31 October 31 October
2025 2024
Current assets
Available for sale investments 2,807,829 2,939,660
Trading investments 58,800 49,953
Trade and other receivables 91,172 52,856
Cash and cash equivalents 228,593 223,712
3,186,394 3,266,181
Current liabilities
Trade and other payables (110,811) (54,338)
PAYE (4,885) (10,806)
Bounce-back Loan (7,500) (10,000)
Total current liabilities (123,196) (75,144)
Net current assets 3,063,198 3,191,037
Bounce-back Loan – long-term - (7,500)
Net assets 3,063,198 3,183,537
Equity
Capital and reserves attributable to equity shareholders
Share capital 955,530 847,530
Share premium 575,790 481,290
Reserve for own shares (50,254) (50,254)
Retained profits/ (losses) 1,403,817 1,739,397
Reserve for share based payments 178,315 165,574
3,063,198 3,183,537
Cash Flow Statement (unaudited)
6 months ended 31 October 31 October
2024
£
Net cash from operating activities
Loss after tax (176,515) (178,261)
Reverse exceptional credits (600) (10,316)
Loss of disposal of investments - 49,837
Provision for share based payments - 15,406
Reverse interest paid 49 255
Operating cash flows before movements in working capital (177,066) (123,079)
Movement in working capital
Decrease/ (increase) in receivables 13,852 (7,950)
(Decrease)/ Increase in payables (17,795) 3,108
Net movement in working capital (3,942) (4,842)
Operating cash out-flow (181,009) (127,921)
Investment activities
Expenditure on available for sale investments - -
Proceeds from sale of investments and options - 108,692
Cash flow from investing activities - 108,692
Financing
202,500 -
Share Capital
(5,000) (5,000)
Bounce-back Loan repayments
(48) (255)
Interest paid
197,452 (5,255)
Net financing
Net Increase / (decrease) in cash and cash equivalents 16,443 (24,484)
Cash and cash equivalents at start of the period 212,150 248,196
Cash and cash equivalents at end of the period 228,593 223,712
Increase / (decrease) in cash and cash equivalents 16,443 (24,484)
This financial information has been prepared in accordance with